Blockage of PLGF improves inflammation, fibrosis, and portal pressure in cirrhotic mice

Christophe Van Steenkiste; Jordi Ribera; Anja Geerts; Sònia Tugues; Peter Carmeliet; Ekhart Verdegem; Louis Libbrecht; Martine De Vos; Hans Van Vlierberghe; Manuel Morales‐Ruiz; Isabelle Colle

Related publications

Article2009

Deficiency in Placental Growth Factor improves inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic mice

Christophe Van Steenkiste, Anja Geerts, Jordi Ribera, Sònia Tugues, Manuel Morales‐Ruiz, Jean Marie Stassen, Peter Carmeliet, Ekhart Verdegem, Louis Libbrecht, Martine De Vos, Hans Van Vlierberghe, Isabelle Colle

Article2011

Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice

Christophe Van Steenkiste, Jordi Ribera, Anja Geerts, Montse Pauta, Sònia Tugues, Christophe Casteleyn, Louis Libbrecht, Kim Olievier, Ben Schroyen, Hendrik Reynaert, Leo A. van Grunsven, Bram Blomme, Stéphanie Coulon, Femke Heindryckx, Martine De Vos, Jean Marie Stassen, Stefan Vinckier, José Altamirano, Ramón Bataller, Peter Carmeliet, Hans Van Vlierberghe, Isabelle Colle, Manuel Morales‐Ruiz

Article2007

Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats

Sònia Tugues, Guillermo Fernández‐Varo, Javier Muñoz, Josefa Ros Velasco, Vicente Arroyo, Juan Rodés, Scott L. Friedman, Peter Carmeliet, Wladimiro Jiménez, Manuel Morales‐Ruiz

Dataset

Faculty Opinions recommendation of Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.

Ralf Weiskirchen

Article2011

599 TRANSDUCTION OF ADENOVIRUS ENCODING DOMINANT-NEGATIVE SOLUBLE PDGFRβ IMPROVES SYSTEMIC HEMODYNAMICS, PORTAL PRESSURE AND HEPATIC FIBROSIS IN RATS CHRONICALLY TREATED WITH CCL4

Guillermo Fernández‐Varo, Vedrana Reichenbach, Josefa Ros Velasco, Ralf Weiskirchen, Gregori Casals, Pedro Melgar‐Lesmes, Manuel Morales‐Ruiz, Wladimiro Jiménez